In a significant step aimed at strengthening patient safety and improving the quality of medicines available in the country, the Central Government has prohibited the manufacture, sale, and distribution of 16 fixed-dose combination (FDC) drugs after an expert review concluded that the formulations lacked adequate therapeutic justification and could pose health risks to patients. The...
